American Journal of Ophthalmology
Volume 135, Issue 1 , Pages 7-13 , January 2003

Expression of extradomain-B–containing fibronectin in subretinal choroidal neovascular membranes

  • Massimo Nicol, MD

      Affiliations

    • Ophthalmology B Section (M.N., F.C.-P., M.Z.), Department of Neurology and Visual Science, University of Genoa, Genoa, Italy
    • ,
  • Attila Bir, MD

      Affiliations

    • Laboratory of Cellular Biology (A.B., P.C., L.Z.), National Institute for Cancer Research, Genoa, Italy
    • ,
  • Felice Cardillo-Piccolino, MD

      Affiliations

    • Ophthalmology B Section (M.N., F.C.-P., M.Z.), Department of Neurology and Visual Science, University of Genoa, Genoa, Italy
    • ,
  • Patrizia Castellani, PhD

      Affiliations

    • Laboratory of Cellular Biology (A.B., P.C., L.Z.), National Institute for Cancer Research, Genoa, Italy
    • ,
  • Alfonso Giovannini, MD

      Affiliations

    • Ophthalmology Clinic (A.G., C.M.), Ancona, Italy
    • ,
  • Cesare Mariotti, MD

      Affiliations

    • Ophthalmology Clinic (A.G., C.M.), Ancona, Italy
    • ,
  • Mario Zingirian, MD

      Affiliations

    • Ophthalmology B Section (M.N., F.C.-P., M.Z.), Department of Neurology and Visual Science, University of Genoa, Genoa, Italy
    • ,
  • Dario Neri, PhD

      Affiliations

    • Department of Applied Biosciences (D.N.), Swiss Federal Institute of Technology, Zurich, Switzerland
    • ,
  • Luciano Zardi, PhD

      Affiliations

    • Laboratory of Cellular Biology (A.B., P.C., L.Z.), National Institute for Cancer Research, Genoa, Italy
    • Corresponding Author InformationInquiries to Luciano Zardi, PhD, Laboratory of Cell Biology, National Institute for Cancer Research, Largo Rosanna Benzi 10, 16132 Genoa, Italy; fax: (+39) 010-352855

,Accepted 14 August 2002.

References 

  1. Amin R, Puklin JE, Frank RN. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci. 1994;35:3178–3188
  2. Baudouin C, Peyman GA, Fredj-Reygrobellet D, et al.  Immunohistological study of subretinal membranes in age-related macular degeneration. Jpn J Ophthalmol. 1992;36:443–451
  3. Gass JD. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol. 1994;118:285–298
  4. Grossniklaus HE, Hutchinson AK, Capone A, Woolfson J, Lambert HM. Clinicopathologic features of surgically excised choroidal neovascular membranes. Ophthalmology. 1994;101:1099–1111
  5. Grossniklaus HE, Martinez JA, Brown VB, et al.  Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1992;114:464–472
  6. Nicolo M, Piccolino FC, Zardi L, Giovannini A, Mariotti C. Detection of tenascin-C in surgically excised choroidal neovascular membranes. Graefes Arch Clin Exp Ophthalmol. 2000;238:107–111
  7. Reddy VM, Zamora RL, Kaplan HJ. Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1995;120:291–301
  8. Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1998;39:2194–2200
  9. Risau W, Lemmon V. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol. 1988;125:441–450
  10. Van den Hoff A. Stromal involvement in malignant growth. Adv Cancer Res. 1988;50:159–196
  11. Madri JA. Extracellular matrix modulation of vascular cell behaviour. Transplant Immunol. 1997;5:179–183
  12. Folkman J, D’Amore PA. Blood vessel formation (what is the molecular basis?). Cell. 1996;87:1153–1155
  13. Zardi L, Carnemolla B, Siri A, et al.  Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. Embo J. 1987;6:2337–2342
  14. Carnemolla B, Balza E, Siri A, et al.  A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol. 1989;108:1139–1148
  15. Castellani P, Viale G, Dorcaratto A, et al.  The fibronectin isoform containing the ED-B oncofetal domain (a marker of angiogenesis). Int J Cancer. 1994;59:612–618
  16. Borsi L, Balza E, Allemanni G, Zardi L. Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues. Exp Cell Res. 1992;199:98–105
  17. Scarpino S, Stoppacciaro A, Pellegrini C, et al.  Expression of EDA/EDB isoforms of fibronectin in papillary carcinoma of the thyroid. J Pathol. 1999;188:163–167
  18. Nickeleit V, Kaufman AH, Zagachin L, Dutt JE, Foster CS, Colvin RB. Healing corneas express embryonic fibronectin isoforms in the epithelium, subepithelial stroma, and endothelium. Am J Pathol. 1996;149:549–558
  19. Cai X, Foster CS, Liu JJ, et al.  Alternatively spliced fibronectin molecules in the wounded cornea (analysis by PCR). Invest Ophthalmol Vis Sci. 1993;34:3585–3592
  20. Ffrench-Constant C, Van de Water L, Dvorak HF, Hynes RO. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol. 1989;109:903–914
  21. Karelina TV, Eisen AZ. Interstitial collagenase and the ED-B oncofetal domain of fibronectin are markers of angiogenesis in human skin tumors. Cancer Detect Prev. 1998;22:438–444
  22. Pau A, Bruzzone L, Dorcaratto A, et al.  Accumulation of oncofetal fibronectin in the vessels of anaplastic meningiomas. J Neurol Neurosurg Psychiatry. 1998;64:412–413
  23. Carnemolla B, Neri D, Castellani P, et al.  Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain. Int J Cancer. 1996;68:397–405
  24. Birchler M, Viti F, Zardi L, Spiess B, Neri D. Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment. Nat Biotechnol. 1999;17:984–988
  25. Scheider A, Gundisch O, Kampik A. Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age–related macular degeneration (results of a prospective study). Graefes Arch Clin Exp Ophthalmol. 1999;237:10–15
  26. Macular Photocoagulation Study Group . Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol. 1994;112:500–509
  27. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group . Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin (one-year results of 2 randomized clinical trials—TAP report). Arch Ophthalmol. 1999;117:1329–1345
  28. Merrill PT, LoRusso FJ, Lomeo MD, Saxe SJ, Khan MM, Lambert HM. Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmology. 1999;106:782–789
  29. Algvere PV, Gouras P, Dafgard Kopp E. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol. 1999;9:217–230
  30. Wolf S, Lappas A, Weinberger AW, Kirchhof B. Macular translocation for surgical management of subfoveal choroidal neovascularizations in patients with AMD (first results). Graefes Arch Clin Exp Ophthalmol. 1999;237:51–57
  31. Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci. 1987;28:506–514
  32. Spirin KS, Saghizadeh M, Lewin SL, Zardi L, Kenney MC, Ljubimov AV. Basement membrane and growth factor gene expression in normal and diabetic human retinas. Curr Eye Res. 1999;18:490–499
  33. Sramek SJ, Wallow IH, Bindley C, Sterken G. Fibronectin distribution in the rat eye. An immunohistochemical study. Invest Ophthalmol Vis Sci. 1987;28:500–505
  34. Ishibashi T, Kohno T, Sorgente N, Patterson R, Ryan SJ. Fibronectin of the chorioretinal interface in the monkey (immunohistochemical and immunoelectron microscopic studies). Graefes Arch Clin Exp Ophthalmol. 1985;223:158–163
  35. Kohno T, Sorgente N, Patterson R, Ryan SJ. Fibronectin and laminin distribution in bovine eye. Jpn J Ophthalmol. 1983;27:496–505
  36. D’Ovidio MC, Mastracchio A, Marzullo A, et al.  Intratumoral microvessel density and expression of ED-A/ED-B sequences of fibronectin in breast carcinoma. Eur J Cancer. 1998;34:1081–1085
  37. Pujuguet P, Hammann A, Moutet M, Samuel JL, Martin F, Martin M. Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. Am J Pathol. 1996;148:579–592
  38. Kishimoto N, Sugasawa K, Kawahara S, et al.  Fibronectin in the chorioretinal wound after laser photocoagulation. Nippon Ganka Gakkai Zasshi. 1993;97:1165–1172
  39. Brown LF, Dubin D, Lavigne L, Logan B, Dvorak HF, Van de Water L. Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am J Pathol. 1993;142:793–801
  40. Spraul CW, Lang GE, Yoon HS, Grossniklaus HE, Lang GK. Histological characterization and classification of surgically excised choroid neovascular membranes. Klin Monatsbl Augenheilkd. 1997;211:324–334
  41. Tarli L, Balza E, Viti F, et al.  A high-affinity human antibody that targets tumoral blood vessels. Blood. 1999;94:192–198
  42. Viti F, Tarli L, Giovannoni L, Zardi L, Neri D. Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis. Cancer Res. 1999;59:347–352

☆ This study was performed at the Ophthalmology Clinic, Ancona (surgical excision) and the Laboratory of Cellular Biology, National Institute for Cancer Research, Genoa (immunohistochemistry).

☆☆ This study was supported in part by funds from the Associazione Italiana per la Ricerca sul Cancro (AIRC) and from the European Commission Grant Identification of Novel Markers of Angiogenesis (BIO4-97-2149). Doctor Birò was supported by a postdoctoral fellowship from the International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.

PII: S0002-9394(02)01839-1

American Journal of Ophthalmology
Volume 135, Issue 1 , Pages 7-13 , January 2003

Article Tools

* Image Usage & Resolution